Arthritis Advisory Committee; Notice of Postponement of Meeting

---
identifier: "/us/fr/E9-3830"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Arthritis Advisory Committee; Notice of Postponement of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "E9-3830"
section_name: "Arthritis Advisory Committee; Notice of Postponement of Meeting"
positive_law: false
currency: "2009-02-24"
last_updated: "2009-02-24"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-3830"
document_type: "notice"
publication_date: "2009-02-24"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "74 FR 8266"
fr_volume: 74
docket_ids:
  - "Docket No. FDA-2009-N-0664"
fr_action: "Notice."
---


#  Arthritis Advisory Committee; Notice of Postponement of Meeting

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is postponing the meeting of the Arthritis Advisory Committee scheduled for March 5, 2009. This meeting was announced in the *Federal Register* of January 29, 2009 (74 FR 5165). The postponement is due to the need to complete the review of additional data submitted by the applicant. Future meeting dates will be announced in the *Federal Register* .

**FOR FURTHER INFORMATION CONTACT:**

Nicole Vesely, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-6793, FAX: 301-827-6776, e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512532. Please call the Information Line for up-to-date information on this meeting.

Dated: February 17, 2009.

Randall W. Lutter,

Deputy Commissioner for Policy.